article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.

article thumbnail

Sustainable energy strategies for pharmaceutical manufacturers

European Pharmaceutical Review

The four governments of the UK established the scheme to increase the climate ambition of the UK’s carbon pricing policy, whilst also protecting the competitiveness of UK businesses. Large energy users such as pharmaceutical manufacturers can play an important role in protecting grid stability while enabling more renewable generation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.

article thumbnail

Innovative pharma-government partnership to enhance UK clinical trials

European Pharmaceutical Review

Sustainable pharmaceutical manufacturing innovation: around 20 percent of the funding will be directed towards initiatives focused on environmentally friendly manufacturing in the industry. The post Innovative pharma-government partnership to enhance UK clinical trials appeared first on European Pharmaceutical Review.

article thumbnail

Pharma responds to 2024 UK General Election

European Pharmaceutical Review

Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government.

Pharma 98
article thumbnail

As pharma abandons the antibiotic market patients are at risk

World of DTC Marketing

“If we do not address the lack of a sustainable market where investments in antibiotics research and development get a fair return, by getting a proper valuation of new antibiotics, our society and our economies will suffer,” says Thomas Cueni, head of the International Federation of Pharmaceutical Manufacturers and Associations.

Marketing 174
article thumbnail

Eli Lilly promises additional $1.6b manufacturing investment

European Pharmaceutical Review

billion and another 200 new jobs is planned for Eli Lilly and Company’s two new pharmaceutical manufacturing sites in Boone County, US. Eli Lilly’s investment here is the largest manufacturing investment at a single location in its history. Students will also be able to access a smart manufacturing lab.